Please login to the form below

Not currently logged in
Email:
Password:

mepolizumab

This page shows the latest mepolizumab news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

microlitre and only when GSK’s Nucala (mepolizumab) is not appropriate.

Latest news

  • PMCPA takes AZ to task over asthma drug press release PMCPA takes AZ to task over asthma drug press release

    The spat comes as Fasenra and Nucala (mepolizumab) are slugging it out in the severe asthma category, with GSK’s drug firmly in the lead - thanks to a two-year lead

  • AZ’s Fasenra hit by COPD trial failure AZ’s Fasenra hit by COPD trial failure

    AZ’s injectable interleukin-5 inhibitor antibody Fasenra (benralizumab), already competing with GSK’s Nucala (mepolizumab) in the severe asthma market, was unable to show a benefit compared to placebo reducing

  • Dermira craters as acne drug fails late-stage test Dermira craters as acne drug fails late-stage test

    s IL-4 and IL-13-targeting drug Dupixent (dupilumab), Pfizer’s new topical treatment Eucrisa (crisaborole) and potentially other drugs such as GlaxoSmithKline’s asthma drug Nucala (mepolizumab), which is

  • AZ gets EMA green light for severe asthma drug Fasenra AZ gets EMA green light for severe asthma drug Fasenra

    Fasenra (benralizumab) is the third IL-5-targetting drug approved for market after GlaxoSmithKline’s Nucala (mepolizumab) and Teva’s Cinqaero (reslizumab) and according to AZ, it is the first biologic

  • GSK gets another approval for Nucala in US GSK gets another approval for Nucala in US

    The US regulator gave the go-ahead yesterday to use Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, inflammation in ... Clinical data demonstrated

More from news
Approximately 10 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics